Boston Scientific Corp (NYSE:BSX)
| 53.60 Delayed Data As of Sep 22 |  -0.37 / -0.69%Today’s Change | 37.74 Today|||52-Week Range 55.38 | +15.84% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2015 | 2016 | 2017 | 2018 | |||
| Revenue and Income | Net Revenues | 7.4B | 8.4B | 9.0B | 9.8B | |
| Cost of Goods Sold | 2.1B | 2.2B | 2.3B | 2.5B | ||
| Depreciation And Amortization | 769.0M | 815.0M | 844.0M | 894.0M | ||
| Operating Expenses | Gross Income | 4.6B | 5.3B | 5.9B | 6.5B | |
| General Expenses | 3.7B | 4.0B | 4.3B | 4.7B | ||
| Other Operating Expenses | 51.0M | 104.0M | 68.0M | 70.0M | ||
| Research And Development | 876.0M | 920.0M | 997.0M | 1.1B | ||
| Total Operating Expenses | 6.6B | 7.2B | 7.5B | 8.1B | ||
| Non-Operating Expenses | Operating Income | 790.0M | 1.2B | 1.5B | 1.7B | |
| Extraordinary Credit | 48.0M | 0.00 | 80.0M | 62.0M | ||
| Extraordinary Charge | -1.4B | -942.0M | -409.0M | -233.0M | ||
| Interest Expense On Debt | 241.0M | 234.0M | 230.0M | 269.0M | ||
| Other Expenses | 123.0M | 112.0M | -38.0M | 122.0M | ||
| Income Taxes, Minority Interest and Extra Items | Pre-Tax Income | -650.0M | 177.0M | 933.0M | 1.4B | |
| Income Taxes | -411.0M | -170.0M | -829.0M | -249.0M | ||
| Net Income | -239.0M | 347.0M | 104.0M | 1.7B | ||
| Shares To Calculate EPS | Shares To Calculate EPS | 1.3B | 1.4B | 1.4B | 1.4B | |
| Shares To Calculate EPS Diluted | 1.3B | 1.4B | 1.4B | 1.4B | ||
| Earnings Per Share | EPS | -$0.18 | $0.25 | $0.08 | $1.19 | |
| EPS Diluted | -$0.18 | $0.25 | $0.07 | $1.19 | ||
